Clinicians' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment.

Autor: Keenan A; Janssen Scientific Affairs, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA. akeenan1@its.jnj.com., Whichello C; Evidera, The Ark, 201 Talgarth Rd, London, W6 8BJ, UK., Le HH; Janssen Scientific Affairs, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA., Kern DM; Janssen Research and Development, 800 Ridgeview Drive, Horsham, PA, 19044, USA., Fernandez GS; Evidera, 7101 Wisconsin Ave # 1400, Bethesda, MD, 20814, USA., Turner V; Evidera, The Ark, 201 Talgarth Rd, London, W6 8BJ, UK., Das A; Evidera, The Ark, 201 Talgarth Rd, London, W6 8BJ, UK., Quaife M; Evidera, The Ark, 201 Talgarth Rd, London, W6 8BJ, UK., Ross AP; Loyola University Chicago, 2160 S 1st Ave, Maywood, IL, 60153, USA.

Publikováno v: PharmacoEconomics - open [Pharmacoecon Open] 2024 Nov; Vol. 8 (6), pp. 857-867. Date of Electronic Publication: 2024 Aug 28.

Benefit-Risk Trade-offs and Patient Preferences for Therapy Selection in Ulcerative Colitis: a Multicountry Preference Study.

Autor: Gisbert JP; Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III Health Institute, Madrid, Spain., Schreiber S; Department of Internal Medicine I, Kiel University, University Hospital Schleswig-Holstein, Kiel, Germany., Siegel CA; Inflammatory Bowel Disease Center, Section of Gastroenterology & Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.; The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Hanover, NH, USA., Magro F; CINTESIS@RISE, Faculty of Medicine, University of Porto, Porto, Portugal., Jus A; Galapagos NV, Leiden, Netherlands., Whichello C; Evidera Inc., London, UK., Michaels-Igbokwe C; Evidera Inc., Montreal, QC, Canada., Heidenreich S; Evidera Inc., London, UK., Oortwijn A; Galapagos NV, Leiden, Netherlands., Vermeire S; Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium.

Publikováno v: Inflammatory bowel diseases [Inflamm Bowel Dis] 2024 Aug 10. Date of Electronic Publication: 2024 Aug 10.

From Qualitative Research to Quantitative Preference Elicitation: An Example in Invasive Meningococcal Disease.

Autor: Coulter J; Pfizer, New York, NY, USA., Whichello C; Evidera, London, UK., Heidenreich S; Evidera, London, UK., Hauber B; Pfizer, New York, NY, USA., Michaels-Igbokwe C; Evidera, St Laurent, QC, Canada., Cappelleri JC; Pfizer, Groton, CT, USA., Peyrani P; Pfizer, Collegeville, PA, USA., Vespa Presa J; Pfizer, Collegeville, PA, USA., Venkatraman M; Evidera, London, UK., Schley K; Pfizer Pharma GmbH, Friedrichstrasse 110, 10117, Berlin, Germany. katharina.schley@pfizer.com.

Publikováno v: The patient [Patient] 2024 May; Vol. 17 (3), pp. 319-333. Date of Electronic Publication: 2024 Feb 23.

What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment.

Autor: Alten R; Schlosspark Klinik, University Medicine Berlin, Berlin, Germany rieke.alten@schlosspark-klinik.de., Nieto-Gonzalez JC; Servicio de Reumatología, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Jacques P; Department of Rheumatology and VIB Inflammation Research Center, University Hospital Ghent, Ghent, Belgium., Montecucco C; Division of Rheumatology, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Moots R; Department of Rheumatology, Aintree University Hospital, Liverpool, UK.; Faculty of Health, Care and Medicine, Edge Hill University, Ormskirk, UK., Radner H; Department of Internal Medicine III, Division of Rheumatology, Medical University Vienna, Vienna, Austria., Vonkeman HE; Department of Rheumatology and Clinical Immunology, Medisch Spectrum Twente, Enschede, The Netherlands.; Department of Psychology, Health & Technology, University of Twente, Enschede, The Netherlands., Heidenreich S; Evidera Inc, London, UK., Whichello C; Evidera Inc, London, UK., Krucien N; Evidera Inc, London, UK., Van Beneden K; Galapagos NV, Mechelen, Belgium.

Publikováno v: RMD open [RMD Open] 2024 Jan 09; Vol. 10 (1). Date of Electronic Publication: 2024 Jan 09.

PCR9 Role of Video Versus Text Information in Willingness to be Vaccinated for Invasive Meningococcal Disease Among US Adolescents/Young Adults and Parents

Autor: Schley, K, Whichello, C, Hauber, B, Krucien, N, Cappelleri, JC, Peyrani, P, Presa, J, Coulter, J, Heidenreich, S

Publikováno v: In Value in Health June 2024 27(6) Supplement:S296-S296